Innovative Funding Models Kidney Care Policy Options for the Future – Roundtable Summary Report

The Institute of Health Economics held a roundtable on June 4, 2015, entitled Innovative Funding Models: Kidney Care Policy Options for the Future, to identify and discuss key issues in kidney care policy options. Prior to the roundtable, an Innovative Funding Models: Kidney Care Policy Options for the Future Steering Committee teleconference refined project objectives, and the agenda and scope of the roundtable. The committee was formed and chaired by Dr. Braden Manns, the Interim Scientific Director of the Alberta Health Services Kidney – Strategic Clinical Network.

The goal of this project was to inform and guide regional and provincial funding approaches for kidney care, while building on best practices and lessons from other jurisdictions. The roundtable provided a shared learning experience involving key stakeholders in government, health service managers, clinical leaders, and industry to ensure key decision-makers are informed by latest evidence and best practices regarding optimal kidney care funding models. To ensure the scope of the project was manageable and consistent with the priorities of health care leaders, this initiative focused on funding models that encouraged the use of home dialysis, a priority for Alberta kidney care policy-makers.

The background materials, including the Innovative Funding Models: Kidney Care Policy Options for the Future roundtable background reading and minutes from the Innovative Funding Models: Kidney Care Policy Options for the Future Steering Committee teleconference, as well as the proceedings of the Innovative Funding Models: Kidney Care Policy Options for the Future roundtable were used to inform the production of this report. The meeting was held under the Chatham House rule, allowing ideas from the meeting to be used without attribution. This document summarizes key points and provides high-level recommendations arising from discussions, but does not represent a consensus view.

This roundtable was supported, financially and/or in-kind, by Baxter Canada, the Alberta Health Services Kidney – Strategic Clinical Network, and Alberta Health via the Health Funding and Economics Capacity (HFEC) Grant.